TuHURA Biosciences Inc reports results for the quarter - Earnings Summary

TuHURA Biosciences

15/11/2024 14:02

* TuHURA Biosciences Inc  HURA.OQ  reported a quarterly
adjusted
loss of $1.37​​ per share for the quarter , higher than the same
quarter last year, when the company reported EPS of $-64.05. 
The lone analyst forecast for the quarter was for a loss of 10
cents per share. 
    * Reported revenue was zero​; analysts expected zero. 
    * TuHURA Biosciences Inc's reported EPS for the quarter was
a loss
of $1.37​.
    * The company reported a quarterly loss of $2.18 million.
    * TuHURA Biosciences Inc shares had fallen by 28.2% this
quarter and lost 17.5% so far this year.

FORECAST CHANGES
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for TuHURA
Biosciences Inc is $15.00 
This summary was machine generated from LSEG data November 15 at
02:02 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.10          -1.37          Missed